Skip to main content

Worldwide Spending on Cancer Drugs Hits $100 Billion

Global spending on cancer drugs hit $100 billion last year, prompted by new and patented drugs, broader insurance coverage and aging populations. That figure is up more than 10 percent since 2013.

Republish
Lead image for this article
Credit: Linus Ekenstam

Global spending on cancer drugs hit $100 billion last year, prompted by new and patented drugs, broader insurance coverage and aging populations. That figure is up slightly more than 10 percent since 2013. (Modern Healthcare)

Texans need truth. Help us report it.

Our Fall Member Drive is underway, and we need your support. The Texas Tribune is a critical source of truth and information for Texans across the state and beyond — and our community of members, the readers who donate, make our work possible. Will you join as a member with a tax-deductible donation of any amount?

Yes, I'll donate today

Information about the authors

Christine Ayala’s staff photo

Explore related story topics